![Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation | Clinical Pharmacokinetics Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation | Clinical Pharmacokinetics](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-021-01090-2/MediaObjects/40262_2021_1090_Fig4_HTML.png)
Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation | Clinical Pharmacokinetics
![Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin [PeerJ] Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2016/1791/1/fig-3-full.png)
Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin [PeerJ]
![Molecules | Free Full-Text | Aspirin Derivative 5-(Bis(3-methylbut-2-enyl)amino)-2-hydroxybenzoic Acid Improves Thermotolerance via Stress Response Proteins in Caenorhabditis elegans Molecules | Free Full-Text | Aspirin Derivative 5-(Bis(3-methylbut-2-enyl)amino)-2-hydroxybenzoic Acid Improves Thermotolerance via Stress Response Proteins in Caenorhabditis elegans](https://pub.mdpi-res.com/molecules/molecules-23-01359/article_deploy/html/images/molecules-23-01359-g001.png?1570165816)
Molecules | Free Full-Text | Aspirin Derivative 5-(Bis(3-methylbut-2-enyl)amino)-2-hydroxybenzoic Acid Improves Thermotolerance via Stress Response Proteins in Caenorhabditis elegans
![Frontiers | Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)? Frontiers | Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?](https://www.frontiersin.org/files/Articles/1080951/falgy-04-1080951-HTML/image_m/falgy-04-1080951-g001.jpg)
Frontiers | Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
![PDF) Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018 PDF) Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018](https://i1.rgstatic.net/publication/352866142_Low-dose_aspirin_for_primary_and_secondary_prevention_of_cardiovascular_events_in_Denmark_1998-2018/links/60dd55ae458515d6fbef034e/largepreview.png)
PDF) Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
![An n→π* Interaction in Aspirin: Implications for Structure and Reactivity | The Journal of Organic Chemistry An n→π* Interaction in Aspirin: Implications for Structure and Reactivity | The Journal of Organic Chemistry](https://pubs.acs.org/cms/10.1021/jo201389d/asset/images/large/jo-2011-01389d_0009.jpeg)